The Facts.
Media

Missed Jumping On The Bitcoin Bandwagon? Anthony Scaramucci Says It’s Not Too Late To Climb Aboard

Anthony Scaramucci, CEO of SkyBridge Capital, suggested that it’s not too late for investors to get on board the Bitcoin (CRYPTO: BTC) boat, as the leading cryptocurrency approaches its all-time high. read more ​ 

Read More
Media

AMD CEO Lisa Su: No ‘One Size Fits All’ In $500B AI Computing Future

Lisa Su, CEO of Advanced Micro Devices Inc., provided an optimistic outlook for the company’s position in the burgeoning artificial intelligence market. read more ​ 

Read More
Media

Meta’s Core Business ‘Doing Great’ With 19% Growth, AI Push Signals Search Monetization Ambitions, Says Gene Munster

Deepwater Asset Management’s Managing Partner Gene Munster offered a detailed analysis of Meta’s third-quarter performance, highlighting the company’s strong core business and ambitious AI investments. read more ​ 

Read More
Media

Qorvo Stock Is Plunging Wednesday: What’s Going On?

Qorvo, Inc. (NASDAQ:QRVO) stock is facing heavy selling pressure Wednesday after the company reported second-quarter financial results and issued third-quarter guidance below estimates. read more ​ 

Read More
Media

Snap Stock Soars After Q3 Earnings Beat: Analysts Optimistic But Say ‘Challenges Remain’

Snap’s shares rose after the company reported upbeat Q3 results. Analysts maintain mixed ratings on expectations of uncertainties continuing into Q4 and the first half of 2025. Latest Ratings for SNAP Date Firm Action From To Mar 2022 Deutsche Bank Initiates Coverage On Buy Mar 2022 Benchmark Initiates Coverage On Buy Feb 2022 Credit Suisse

Read More
Media

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results

Latest Ratings for TXG Date Firm Action From To Feb 2022 Citigroup Maintains Buy Nov 2021 Morgan Stanley Maintains Overweight Sep 2021 National Bank Of Canada Initiates Coverage On Sector Perform View More Analyst Ratings for TXG View the Latest Analyst Ratings read more ​ 

Read More
Media

BioMarin’s Pipeline Faces Skepticism As Analyst Questions Future Growth

BioMarin posts Q3 EPS of $0.91, nearly doubling last year’s $0.46 and topping estimates. Sales rose 28%, driven by strong Voxzogo growth. Analyst downgrades on lack of upcoming catalysts. Latest Ratings for BMRN Date Firm Action From To Feb 2022 Piper Sandler Maintains Overweight Nov 2021 Credit Suisse Maintains Outperform Nov 2021 Morgan Stanley Maintains

Read More
Media

Apple Refreshes MacBook Pro Lineup With M4 Pro and M4 Max 3Nm Chips

Apple unveils M4 Pro and M4 Max chips with 3nm technology for Mac. Features include faster cores, Thunderbolt 5, and Apple Intelligence. read more ​ 

Read More
Media

Peering Into Home Depot’s Recent Short Interest

read more ​ 

Read More
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.